Remifentanil was designed to serve as a strong anesthetic with an ultra-short and predictable duration that would not have accumulation issues. Remifentanil is patented by Glaxo Wellcome Inc. and was FDA approved on July 12, 1996. Pricing for Ultiva. 1 mg vial - 30.19 USD; 3 mg vial - 57.20 USD; 5 mg vial - 118.15 USD
Breach of contract is a legal cause of action in which a binding agreement or bargained-for exchange is not honored by one or more of the parties to the contract by non-performance or interference with the other party's performance.
A breach of contract is a failure to fulfill the duties under the contract terms. A contract can be breached in the following ways: 1  One party does not perform as he or she promised. 2  One party does something that makes it impossible for the other party to perform the duties under the contract. 3  One party makes it clear that he or she does not intend to perform the contract duties.